Navigation Links
Trimedyne Reports Financial Results For The Quarter And Fiscal Year Ended September 30, 2012
Date:2/1/2013

LAKE FOREST, Calif., Feb. 1, 2013 /PRNewswire/ -- TRIMEDYNE, INC. (OTCBB "TMED") reported revenues of $6,080,000 for the fiscal year ended September 30, 2012, a 9% decrease from revenues of $6,656,000 for the prior fiscal year.  The decrease in revenues was largely due to a decrease in sales of Lasers, partially offset by an increase in sales of Fibers, Needles and Tips.

The Company had an operating loss of $1,170,000 for the 2012 fiscal year, compared to an operating loss of $1,522,000 for the prior fiscal year.  Due to economies instituted in the past year, the Company had net loss of $836,000 or $0.05 per share for the fiscal year ended September 30, 2012, as compared to a net loss of $1,486,000 or $0.08 per share for the prior fiscal year.

For the quarter ended September 30, 2012, the Company had revenues of $1,449,000, a 16% decrease from revenues of $1,732,000 for the same quarter of the prior year.  Due to economies instituted in the past year, the Company had an operating loss of $340,000 for the quarter ended September 30, 2012, compared to an operating loss of $683,000 for the same quarter of the prior year.  The Company had a net loss of $314,000 or $0.02 per share for the quarter ended September 30, 2012, versus a net loss of $689,000 or $0.04 per share for the year earlier quarter.

Included in the cost of sales for the fiscal year and quarter ended September 30, 2012, was a charge for excess and obsolete inventory of $225,000.  Without this non-cash charge, the Company's loss from operations for the fiscal year and quarter ended September 30, 2012, would have been $945,000 and $115,000, respectively, and the Company's net loss for the fiscal year and quarter ended September 30, 2012, would have been $611,000 and $89,000, respectively.

The Company ended the 2012 fiscal year with cash and equivalents of $472,000 and receivables and other current assets of $651,000, versus accounts payable and accrued expenses of $501,000.

The Company is aggressively pursuing financing for the seven (7) subsidiaries the Company plans to organize to conduct clinical trials of the Company's breakthrough lasers and optical fiber devices to treat a variety of medical conditions, as described in the Company's Press Release of November 28, 2012.

Trimedyne manufactures proprietary Holmium lasers and patented fiber optic laser devices for vaporizing the prostate to treat BPH, vaporizing spinal disc tissue to treat herniated or ruptured discs and in a variety of other, minimally invasive procedures, many of which are performed on an outpatient basis at substantially less cost than conventional surgery.  For product, press release, financial, SEC Reports and other information, please visit Trimedyne's website, http://www.trimedyne.com.    

"Safe Harbor" Statement Under  the Private Securities Litigation Reform Act:
Statements in this news release may contain forward-looking statements within the meaning of Section 27A of the U.S. Securities Act of 1933 and Section 21E of the Securities and Exchange Act of 1934, including words like "expect", "may", "could" and others.  Such statements may involve various risks and uncertainties, some of which may be discussed in the Company's current Form 10-K Report and subsequently filed SEC reports.  There is no assurance such statements will prove to be accurate, and actual results and future events could differ materially from those anticipated in such statements.

CONTACT:

Jeffrey Rudner


(949) 951-3800, Ext. 285


jrudner@trimedyne.com


'/>"/>
SOURCE Trimedyne, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Qmed, the Leading Global MedTech Industry Resource, Partners with Clarimed, to Provide the Medical Manufacturing and Healthcare Industry with FDA Reports on Adverse Events
2. Sigma-Aldrich (NASDAQ: SIAL) Reports Q1 2012 Diluted EPS of $0.96, With Diluted Adjusted EPS of $0.99. Sales Increase 5% for Q1 2012. Full Year 2012 Diluted Adjusted EPS Outlook of $3.90 to $4.05 Reaffirmed.
3. Kelyniam Global Inc. Reports Record Cranial Implant Revenues in the 1st Quarter of 2012
4. Varian Medical Systems Reports Results for Second Quarter of Fiscal Year 2012
5. Mylan Reports Q1 2012 Adjusted Diluted EPS of $0.52, an 18% Increase Over Prior Year Quarter
6. CryoLife Reports Record Quarterly Revenues in First Quarter of 2012
7. PAREXEL Reports Third Quarter Fiscal Year 2012 Financial Results
8. Luminex Corporation Reports First Quarter 2012 Results
9. Hospira Reports First-Quarter 2012 Results
10. Endo Reports First Quarter Financial Results And Announces Return To Steady Supply Of OPANA® ER And Voltaren® Gel
11. The Female Health Company Reports Second Quarter Operating Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/1/2017)... SAN FRANCISCO , March 1, 2017 The global  ... based on a new report by Grand View Research, Inc. The intraoperative neuromonitoring ... be attributed to the hospitals adopting intraoperative monitoring in a wide spectrum of ... ... Grand View Research Logo ...
(Date:3/1/2017)... , Italia, March 1, 2017 El mismo sistema se mostrará ... Continue Reading ... The open MRI scanner - MROpen ... ... MROpen en el Reino Unido y la primera en Gales. El escáner se localizará en ...
(Date:2/28/2017)... , Feb. 28, 2017 Mechanical Ventilators ... full report: https://www.reportbuyer.com/product/4402626/ This report ... on the global and regional levels. It provides historical ... 2024 in terms of revenue (US$ Mn) and volume ... an outlook on mechanical ventilators sales globally. It includes ...
Breaking Medicine Technology:
(Date:3/1/2017)... ... March 01, 2017 , ... Both incentives and restrictions ... Assistance Program (SNAP) can reduce food insecurity. Findings are presented in three new ... Journal of Preventive Medicine . , Researchers examined data from two large random ...
(Date:3/1/2017)... ... March 01, 2017 , ... Look for a new ... of Roses and Drift Roses. Star Roses and Plants is launching their new ... , The Bushel and Berry Collection makes growing fresh fruit simple with a variety ...
(Date:3/1/2017)... ... March 01, 2017 , ... ... release of its 2017 update to Compass, the popular online learning system ... , Suitable for standardizing both new-hire on-boarding and annual competency-validation, Compass teaches ...
(Date:3/1/2017)... ... March 01, 2017 , ... Breast Surgeon, Dr. Dennis ... of early stage breast cancer and where it fits in the treatment paradigm at ... We Make .” The event brings together leading cancer and wellness experts to share ...
(Date:3/1/2017)... ... , ... Award-winning medical group Allied Anesthesia today announced that, as of 2016, ... more than one trip per year since 1998. Char was named the Los Angeles ... details of his charitable work. Char has been an Allied Anesthesiologist since 2000. , ...
Breaking Medicine News(10 mins):